2 not yet recruiting, 2 recruiting, 1 active not recruiting, 1 completed. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Frontotemporal Lobar Degeneration (FTLD): new trials by email Literature Review of Frontotemporal Lobar Degeneration (FTLD) trials Research Report on Frontotemporal Lobar Degeneration (FTLD)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Wearable Sensor Platform for Remote Monitoring of Individuals on the Frontotemporal Dementia Spectrum Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD) | Not yet recruiting | BioSensics | 60 | 2026-11-01 | 2026-10-13 | |
| Digital Measurements of Motor and Voice Functions in FTD Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD) | Not yet recruiting | BioSensics | 20 | 2026-08-01 | 2026-04-28 | |
| Single-centre Descriptive Study of Taste in Frontotemporal Lobar Degeneration Through the Analysis of Taste Evoked Potentials Blood test, Interrogation of the subject, Cognitive assessment - Frontotemporal Lobar Degeneration (FTLD) | Not applicable | Recruiting | Centre Hospitalier Universitaire Dijon | 20 | 2025-08-18 | 2025-08-24 |
| Neuroinflammation in FTLD 7T MRI scan, CSF, Blood withdrawal - Corticobasal Syndrome(CBS), Primary Progressive Aphasia(PPA) | Active not recruiting | Leiden University Medical Center | 110 | 2023-07-25 | 2025-09-11 | |
| ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD) Frontotemporal Lobar Degeneration (FTLD), Progressive Supranuclear Palsy (PSP) | Recruiting | Mayo Clinic | 2100 | 2020-03-01 | 2026-10-07 | |
| Biomarkers in Neurodegenerative Diseases Neuraceq - Mild Cognitive Impairment (MCI), Alzheimer Disease (AD) | Withdrawn | University of Minnesota | 2019-10-01 | 2019-11-12 | ||
| Tau PET Imaging With 18F-AV-1451 in Subjects With MAPT Mutations 18F-AV-1451 - Frontotemporal Lobar Degeneration (FTLD), Frontotemporal Dementia (FTD) | Phase 2 | Completed | Columbia University | 7 | 2016-04-01 | 2019-12-06 |
Frontotemporal Lobar Degeneration (7) · Corticobasal Degeneration (4) · Frontotemporal Dementia (4) · Amyotrophic Lateral Sclerosis (2) · Supranuclear Palsy, Progressive (2) · Alzheimer Disease (1) · Aphasia, Primary Progressive (1) · Cognitive Dysfunction (1) · Epilepsy, Temporal Lobe (1) · Frontotemporal Dementia With Motor Neuron Disease (1) · Lewy Body Disease (1) · Motor Neuron Disease (1) · Nerve Degeneration (1) · Neuroinflammatory Diseases (1) · Spinocerebellar Ataxias (1)
Brain Diseases (7) · Central Nervous System Diseases (7) · Dementia (7) · Mental Disorders (7) · Metabolic Diseases (7) · Nervous System Diseases (7) · Neurocognitive Disorders (7) · Neurodegenerative Diseases (7) · Nutritional and Metabolic Diseases (7) · Proteostasis Deficiencies (7) · TDP-43 Proteinopathies (7) · Tauopathies (5) · Basal Ganglia Diseases (3) · Movement Disorders (3) · Neurologic Manifestations (3)
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene (1) · 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole (1) · Hematologic Tests (1) · Mental Status and Dementia Tests (1) · Nutrition Assessment (1)
BioSensics (2) · Centre Hospitalier Universitaire Dijon (1) · Columbia University (1) · Leiden University Medical Center (1) · Mayo Clinic (1) · University of Minnesota (1)
United States (4) · Canada (1) · France (1) · Netherlands (1)
Adam Boxer, MD, PhD (1) · Bradley Boeve, MD (1) · Edward Huey, MD (1) · Howie Rosen, MD (1) · Keith Vossel, MD, MSc (1)
R01NS076837 (1), U19AG063911 (1)